Search
01/02/2024
The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia
Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2024; 581DOI:10.1016/j.mce.2023.112113. PMID:37989409. IF:3.600(Q2/4D).
01/02/2024
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting
Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Giménez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mir, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. DIABETES CARE. 2024; 47(2)DOI:10.2337/dc23-1355. PMID:37948469. IF:16.600(Q1/1D).
01/02/2024
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data
Villanueva, C, Sapena, V, Lo, GH, Seo, YS, Shah, HA, Singh, V, Tripathi, D, Schepke, M, Gheorghe, C, Bonilha, DQ, Jutabha, R, Wang, HM, Rodrigues, SG, Brujats, A, Lee, HA, Azam, Z, Kumar, P, Hayes, PC, Sauerbruch, T, Chen, WC, Iacob, S, Libera, ED, Jensen, DM, Alvarado, E, Torres, F, Bosch, J. Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 59(3)DOI:10.1111/apt.17824. PMID:38108646. IF:6.700(Q1/1D).
01/02/2024
Assessment, Treatment, and Follow-Up of Phlebitis Related to Peripheral Venous Catheterisation: A Delphi Study in Spain
Torné-Ruiz, A, Reguant, M, Sanromà-Ortiz, M, Piriz, M, Roca, J, García-Expósito, J. Assessment, Treatment, and Follow-Up of Phlebitis Related to Peripheral Venous Catheterisation: A Delphi Study in Spain. Healthcare. 2024; 12(3)DOI:10.3390/healthcare12030378. PMID:38338263. IF:2.700(Q2/4D).
01/02/2024
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register
Molina-Collada, J, Alonso, F, Otero, L, Bohórquez, C, Torné, CD, García, CP, Madrigal, JMB, Vela, P, Alvaro-Gracia, JM, Castrejón, I. Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024; 64DOI:10.1016/j.semarthrit.2023.152341. PMID:38128174. IF:4.400(Q1/1D).
01/02/2024
Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study
López-Medina, C, Calvo-Gutiérrez, J, Abalos-Aguilera, MC, Cepas, F, Plasencia-Rodríguez, C, Martínez-Feito, A, Balsa, A, Faré-García, R, Juan-Mas, A, Ruiz-Esquide, V, Sainz, L, Díaz-Torné, C, Godoy-Navarrete, FJ, Añón-Oñate, I, Mena-Vázquez, N, Manrique-Arija, S, Moreno-García, MS, Ortega-Castro, R, Escudero-Contreras, A. Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study. RMD Open. 2024; 10(1)DOI:10.1136/rmdopen-2023-003975. PMID:38395455. IF:4.700(Q1/1D).
01/02/2024
The splicing factor SF3B1 is involved in brown adipocyte thermogenic activation
Castellá, M, Mestres-Arenas, A, Gavaldà-Navarro, A, Blasco-Roset, A, Quesada-López, T, Romero-Carramiñana, I, Giralt, M, Villarroya, F, Cereijo, R. The splicing factor SF3B1 is involved in brown adipocyte thermogenic activation. BIOCHEMICAL PHARMACOLOGY. 2024; 220DOI:10.1016/j.bcp.2023.116014. PMID:38158020. IF:5.600(Q1/1D).
01/02/2024
The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families
Schreurs, MAC, Cajal, TRY, Adank, MA, Collee, JM, Hollestelle, A, van Rooij, J, Schmidt, MK, Hooning, MJ. The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families. BREAST. 2024; 73DOI:10.1016/j.breast.2023.103611. PMID:38039887. IF:7.900(Q1/1D).
01/02/2024
Peapod FOS trial: A phase 2 clinical trial of pembrolizumab in combination with carboplatin and cabazitaxel in aggressive variant metastatic castration-resistant prostate cancer.
Villarrubia, JE, Gordoa, TA, Mellado-González, B, Duran, I, Pinto, A, Sanchez, A, Pous, AF, Vazquez-Estevez, S, Puente, J, Grande, E, Climent, MA, Maroto-Rey, P, Perez-Gracia, JL, Aix, SP, Castellano, D, Gonzalez-Billalabeitia, E. Peapod FOS trial: A phase 2 clinical trial of pembrolizumab in combination with carboplatin and cabazitaxel in aggressive variant metastatic castration-resistant prostate cancer.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(4_SUPPL)DOI:10.1200/JCO.2024.42.4_suppl.TPS238. PMID:. IF:41.900(Q1/1D).
01/02/2024
External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy
Pujol, A, León, X, Holgado, A, Valero, C, Kolanczak, K, Quer, M, Virós, D. External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy. ORAL ONCOLOGY. 2024; 149DOI:10.1016/j.oraloncology.2024.106686. PMID:38218021. IF:3.900(Q1/2D).
01/02/2024
Serum from Stroke Patients with High-Grade Carotid Stenosis Promotes Cyclooxygenase-Dependent Endothelial Dysfunction in Non-ischemic Mice Carotid Arteries
Puertas-Umbert, L, Puig, N, Camacho, M, Dantas, AP, Marin, R, Marti-Fabregas, J, Jimenez-Xarrie, E, Benitez, S, Camps-Renom, P, Jimenez-Altayo, F. Serum from Stroke Patients with High-Grade Carotid Stenosis Promotes Cyclooxygenase-Dependent Endothelial Dysfunction in Non-ischemic Mice Carotid Arteries. Translational Stroke Research. 2024; 15(1)DOI:10.1007/s12975-022-01117-1. PMID:36536168. IF:4.300(Q1/2D).
01/02/2024
Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function
Quesada-López, T, Cereijo, R, Blasco-Roset, A, Mestres-Arenas, A, Prieto, P, Domingo, JC, Villarroya, F, Domingo, P, Giralt, M. Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function. BIOCHEMICAL PHARMACOLOGY. 2024; 220DOI:10.1016/j.bcp.2023.116010. PMID:38154544. IF:5.600(Q1/1D).
01/02/2024
Correction: Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.
Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg AJ, Kessler U, Sartorius A, Dols A, Narr KL, Espinoza R, van Waarde JA, Tendolkar I, van Eijndhoven P, van Wingen GA, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Paulson OB, Yrondi A, Péran P, Soriano-Mas C, Cardoner N, Cano M, van Diermen L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders PC, Redlich R, Dannlowski U, Kavakbasi E, Kritzer MD, Ellard KK, Camprodon JA, Petrides G, Malhotra AK, Abbott CC. Correction: Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.. MOLECULAR PSYCHIATRY. 2024; 29(2)DOI:10.1038/s41380-023-02358-8. PMID:38052984. IF:(Q/D).
01/02/2024
Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression
Argyelan, M, Deng, ZD, Ousdal, OT, Oltedal, L, Angulo, B, Baradits, M, Spitzberg, AJ, Kessler, U, Sartorius, A, Dols, A, Narr, KL, Espinoza, R, van Waarde, JA, Tendolkar, I, van Eijndhoven, P, van Wingen, GA, Takamiya, A, Kishimoto, T, Jorgensen, MB, Jorgensen, A, Paulson, OB, Yrondi, A, Péran, P, Soriano-Mas, C, Cardoner, N, Cano, M, van Diermen, L, Schrijvers, D, Belge, JB, Emsell, L, Bouckaert, F, Vandenbulcke, M, Kiebs, M, Hurlemann, R, Mulders, PCR, Redlich, R, Dannlowski, U, Erhan, K, Kritzer, MD, Ellard, KK, Camprodon, JA, Petrides, G, Malhotra, AK, Abbott, CC. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression. MOLECULAR PSYCHIATRY. 2024; 29(2)DOI:10.1038/s41380-023-02318-2. PMID:37985787. IF:10.100(Q1/1D).
01/02/2024
An international Delphi consensus for surgical quality assessment of lymphadenectomy and anastomosis in minimally invasive total gastrectomy for gastric cancer.
Cizmic A, Romic I, Balla A, Barabino N, Anania G, Baiocchi GL, Bakula B, Balagué C, Berlth F, Bintintan V, Bracale U, Egberts JH, Fuchs HF, Gisbertz SS, Gockel I, Grimminger P, van Hillegersberg R, Inaki N, Immanuel A, Korr D, Lingohr P, Mascagni P, Melling N, Milone M, Mintz Y, Morales-Conde S, Moulla Y, Müller-Stich BP, Nakajima K, Nilsson M, Reeh M, Sileri P, Targarona EM, Ushimaru Y, Kim YW, Markar S, Nickel F, Mitra AT. An international Delphi consensus for surgical quality assessment of lymphadenectomy and anastomosis in minimally invasive total gastrectomy for gastric cancer.. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2024; 38(2)DOI:10.1007/s00464-023-10614-9. PMID:38148401. IF:2.700(Q1/3D).
01/02/2024
Are the minimally invasive techniques the new gold standard in thymus surgery for myasthenia gravis? Experience of a reference single-site in VATS thymectomy
Reyes, JCT, Tellez, EM, Sanchis, JB, Canovas, GP, Niño, AL, Guarino, M, Ferrandez, JH, Duarte, AM. Are the minimally invasive techniques the new gold standard in thymus surgery for myasthenia gravis? Experience of a reference single-site in VATS thymectomy. Frontiers in Neurology. 2024; 15DOI:10.3389/fneur.2024.1309173. PMID:38361645. IF:2.800(Q2/5D).
01/02/2024
Availability of antidotes in the primary care emergency centers of Catalonia
Salmerón, RA, Ametller, MAG, Albiach, AMJ, Sánchez, LM, Martínez, EFD, Cardús, ASI. Availability of antidotes in the primary care emergency centers of Catalonia. EMERGENCIAS. 2024; 36(1)DOI:10.55633/s3me/07.2023. PMID:38318746. IF:6.300(Q1/1D).
01/02/2024
Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)
Reich, K, Bianchi, L, Khemis, A, Maul, JT, Tsianakas, A, Schempp, CM, Petersen, K, Noergaard, MM, Puig, L. Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA). Dermatology and Therapy. 2024; 14(2)DOI:10.1007/s13555-023-01092-x. PMID:38300408. IF:4.200(Q1/1D).
01/02/2024
Epidemiological Characteristics and Factors Associated with Repeat Sexually Transmitted Infections in Barcelona, Spain Over a Decade
Jacques-Aviñó C., Alarcón Guitiérrez M., Barbera M.J., Fuertes I., Martin-Ezquerra G., Lopez-Contreras J., Vives Á., Rodriguez R., Ros M., Rius C., De Olalla P.G.. Epidemiological Characteristics and Factors Associated with Repeat Sexually Transmitted Infections in Barcelona, Spain Over a Decade. ARCHIVES OF SEXUAL BEHAVIOR. 2024; 53(2)DOI:10.1007/s10508-023-02711-6. PMID:37875628. IF:2.900(Q1/1D).
30/01/2024
Quitline nurses' experiences in providing telephone-based smoking cessation help to mental health patients: A mixed methods study
Rosa, N, Feliu, A, Ballbè, M, Alaustre, L, Vilalta, E, Torres, N, Nieva, G, Pla, M, Pinet, C, Raich, A, Mondon, S, Barrio, P, Andreu, M, Suelves, JM, Vilaplana, J, Enríquez, M, Castellano, Y, Guydish, J, Fernández, E, Martínez, C. Quitline nurses' experiences in providing telephone-based smoking cessation help to mental health patients: A mixed methods study. Journal of Psychiatric and Mental Health Nursing. 2024; DOI:10.1111/jpm.13012. PMID:38288784. IF:2.900(Q1/2D).